The Food and Drug Administration (FDA or Agency) has determined that VAGIFEM (estradiol) Vaginal Tablets, 25 micrograms, was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.
Document
Determination That VAGIFEM (Estradiol) Vaginal Tablets, 25 Micrograms, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that VAGIFEM (estradiol) Vaginal Tablets, 25 micrograms, was not withdrawn from sale for reasons of safety or eff...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 29720
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Determination That VAGIFEM (Estradiol) Vaginal Tablets, 25 Micrograms, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” thefederalregister.org (May 22, 2015), https://thefederalregister.org/documents/2015-12396/determination-that-vagifem-estradiol-vaginal-tablets-25-micrograms-was-not-withdrawn-from-sale-for-reasons-of-safety-or-.